These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17728122)

  • 1. Erasing pleasure from public discourse on illicit drugs: on the creation and reproduction of an absence.
    Moore D
    Int J Drug Policy; 2008 Oct; 19(5):353-8. PubMed ID: 17728122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putting at risk what we know: reflecting on the drug-using subject in harm reduction and its political implications.
    Moore D; Fraser S
    Soc Sci Med; 2006 Jun; 62(12):3035-47. PubMed ID: 16413645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pleasure in context.
    Duff C
    Int J Drug Policy; 2008 Oct; 19(5):384-92. PubMed ID: 17768037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of pleasure in harm reduction: perspectives from the history of sexuality.
    Race K
    Int J Drug Policy; 2008 Oct; 19(5):417-23. PubMed ID: 17904347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction.
    Irwin KS; Fry CL
    Int J Drug Policy; 2007 Mar; 18(2):75-83. PubMed ID: 17689348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volatile bodies: stories of corporeal pleasure and damage in marginalised young people's drug use.
    MacLean S
    Int J Drug Policy; 2008 Oct; 19(5):375-83. PubMed ID: 17900889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Privileging pleasure: temazepam injection in a heroin marketplace.
    Dwyer R
    Int J Drug Policy; 2008 Oct; 19(5):367-74. PubMed ID: 17997090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ushering in another harm reduction era? Discursive authenticity, drug policy and research.
    Hathaway AD
    Drug Alcohol Rev; 2005 Nov; 24(6):549-50. PubMed ID: 16361211
    [No Abstract]   [Full Text] [Related]  

  • 9. Trauma, damage and pleasure: rethinking problematic drug use.
    Valentine K; Fraser S
    Int J Drug Policy; 2008 Oct; 19(5):410-6. PubMed ID: 17875389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk environments and drug harms: a social science for harm reduction approach.
    Rhodes T
    Int J Drug Policy; 2009 May; 20(3):193-201. PubMed ID: 19147339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleasure and discipline in the uses of Ritalin.
    Keane H
    Int J Drug Policy; 2008 Oct; 19(5):401-9. PubMed ID: 17884422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Kiddie drugs' and controlled pleasure: recreational use of dexamphetamine in a social network of young Australians.
    Green R; Moore D
    Int J Drug Policy; 2009 Sep; 20(5):402-8. PubMed ID: 19168342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How the harm reduction movement contrasts itself against punitive prohibition.
    Tammi T; Hurme T
    Int J Drug Policy; 2007 Mar; 18(2):84-7. PubMed ID: 17689349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding post 9/11 drug control policy and politics in Central Asia.
    Latypov A
    Int J Drug Policy; 2009 Sep; 20(5):387-91. PubMed ID: 19121928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using words: the harm reduction conception of drug use and drug users.
    Stafford N
    Int J Drug Policy; 2007 Mar; 18(2):88-91. PubMed ID: 17689350
    [No Abstract]   [Full Text] [Related]  

  • 16. Harm reduction ethics: a promising basis for drug policy.
    Miller P
    Drug Alcohol Rev; 2005 Nov; 24(6):553-4. PubMed ID: 16361213
    [No Abstract]   [Full Text] [Related]  

  • 17. Applied communitarian ethics for harm reduction: promoting a dialogue within the field.
    Fry C; Treloar C; Maher L
    Drug Alcohol Rev; 2007 Sep; 26(5):553-5. PubMed ID: 17701519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization and harm reduction: research avenues and policy agendas.
    Erickson PG; Hathaway AD
    Int J Drug Policy; 2010 Mar; 21(2):137-9. PubMed ID: 20022234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The issue of harm reduction in Polish legislation concerning drug addiction. A comparative study].
    Sobeyko J
    Ann Acad Med Stetin; 2008; 54(2):119-31. PubMed ID: 19374242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Political science, public policy, and drug use prevention.
    Pentz MA; Mares D; Schinke S; Rohrbach LA
    Subst Use Misuse; 2004; 39(10-12):1821-65. PubMed ID: 15587952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.